| First Author | Herro R | Year | 2015 |
| Journal | J Invest Dermatol | Volume | 135 |
| Issue | 8 | Pages | 2109-2118 |
| PubMed ID | 25789702 | Mgi Jnum | J:222976 |
| Mgi Id | MGI:5646099 | Doi | 10.1038/jid.2015.110 |
| Citation | Herro R, et al. (2015) The Tumor Necrosis Factor Superfamily Molecule LIGHT Promotes Keratinocyte Activity and Skin Fibrosis. J Invest Dermatol 135(8):2109-18 |
| abstractText | Several inflammatory diseases including scleroderma and atopic dermatitis display dermal thickening, epidermal hypertrophy, or excessive accumulation of collagen. Factors that might promote these features are of interest for clinical therapy. We previously reported that LIGHT, a TNF superfamily molecule, mediated collagen deposition in the lungs in response to allergen. We therefore tested whether LIGHT might similarly promote collagen accumulation and features of skin fibrosis. Strikingly, injection of recombinant soluble LIGHT into naive mice, either subcutaneously or systemically, promoted collagen deposition in the skin and dermal and epidermal thickening. This replicated the activity of bleomycin, an antibiotic that has been previously used in models of scleroderma in mice. Moreover skin fibrosis induced by bleomycin was dependent on endogenous LIGHT activity. The action of LIGHT in vivo was mediated via both of its receptors, HVEM and LTbetaR, and was dependent on the innate cytokine TSLP and TGF-beta. Furthermore, we found that HVEM and LTbetaR were expressed on human epidermal keratinocytes and that LIGHT could directly promote TSLP expression in these cells. We reveal an unappreciated activity of LIGHT on keratinocytes and suggest that LIGHT may be an important mediator of skin inflammation and fibrosis in diseases such as scleroderma or atopic dermatitis. |
